512 related articles for article (PubMed ID: 31322184)
1. Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt/mTOR pathway and acceleration of cell cycle.
Han Y; Liu C; Zhang D; Men H; Huo L; Geng Q; Wang S; Gao Y; Zhang W; Zhang Y; Jia Z
Int J Oncol; 2019 Sep; 55(3):629-644. PubMed ID: 31322184
[TBL] [Abstract][Full Text] [Related]
2. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
3. Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling.
Zhang S; Cao S; Gong M; Zhang W; Zhang W; Zhu Z; Wu S; Yue Y; Qian W; Ma Q; Wang S; Wang Z
Cancer Biol Ther; 2022 Dec; 23(1):336-347. PubMed ID: 36112948
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
6. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
Hung CM; Lin YC; Liu LC; Kuo SC; Ho CT; Way TD
Chem Biol Interact; 2016 Dec; 260():1-12. PubMed ID: 27769712
[TBL] [Abstract][Full Text] [Related]
7. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract][Full Text] [Related]
8. Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis.
Wang X; Cheng G; Miao Y; Qiu F; Bai L; Gao Z; Huang Y; Dong L; Niu X; Wang X; Li Y; Tang H; Xu Y; Song X
J Cell Mol Med; 2021 Feb; 25(4):2238-2253. PubMed ID: 33439514
[TBL] [Abstract][Full Text] [Related]
9. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
10. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer.
Gao N; Zhang Z; Jiang BH; Shi X
Biochem Biophys Res Commun; 2003 Oct; 310(4):1124-32. PubMed ID: 14559232
[TBL] [Abstract][Full Text] [Related]
11. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the Piezo1 channel protects microglia from acute hyperglycaemia damage through the JNK1 and mTOR signalling pathways.
Liu H; Bian W; Yang D; Yang M; Luo H
Life Sci; 2021 Jan; 264():118667. PubMed ID: 33127514
[TBL] [Abstract][Full Text] [Related]
13. Mechanical force modulates macrophage proliferation via Piezo1-AKT-Cyclin D1 axis.
Xu H; Guan J; Jin Z; Yin C; Wu S; Sun W; Zhang H; Yan B
FASEB J; 2022 Aug; 36(8):e22423. PubMed ID: 35775626
[TBL] [Abstract][Full Text] [Related]
14. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Valeriote FA; Gautam SC
J Exp Ther Oncol; 2016 Nov; 11(4):251-260. PubMed ID: 27849335
[TBL] [Abstract][Full Text] [Related]
15. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889
[TBL] [Abstract][Full Text] [Related]
16. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
[TBL] [Abstract][Full Text] [Related]
17. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.
Li JZ; Wang ZL; Xu WH; Li Q; Gao L; Wang ZM
Cancer Invest; 2016; 34(4):181-8. PubMed ID: 27031291
[TBL] [Abstract][Full Text] [Related]
19. Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytes.
Sasaki F; Hayashi M; Mouri Y; Nakamura S; Adachi T; Nakashima T
Biochem Biophys Res Commun; 2020 Jan; 521(3):806-813. PubMed ID: 31708103
[TBL] [Abstract][Full Text] [Related]
20. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
Xu S; Ge J; Zhang Z; Zhou W
Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
